Get started free →
SRES 786 119th Congress · Senate

Senate Declares July 15, 2026, Glioblastoma Awareness Day

Advocate

Official title: A resolution designating July 15, 2026, as "Glioblastoma Awareness Day".

This Senate resolution designates July 15, 2026, as "Glioblastoma Awareness Day" to spotlight a particularly aggressive form of brain cancer. It does not create a federal program, spending commitment, or benefit, but it gives the disease national recognition in the Senate and encourages public awareness, education, and support for research and treatment efforts. The measure applies symbolically to patients, families, caregivers, researchers, and advocacy groups focused on glioblastoma. It was agreed to by unanimous consent in the Senate.

  • Designates July 15, 2026, as "Glioblastoma Awareness Day"
  • Passed the Senate by unanimous consent on June 23, 2026
  • Creates no new federal benefits, mandates, or spending program
  • Focuses attention on glioblastoma patients, caregivers, and researchers
Public Relevance 5 / 100
Niche Narrow / procedural Broad

For the general public, this resolution has no direct financial cost or benefit and does not change any federal rights, eligibility rules, or coverage. The main effect is symbolic: it may increase awareness of glioblastoma and encourage support for research, patient advocacy, and caregiver resources, especially among people affected by brain cancer.

See how this bill affects you — sign in for a personalized analysis

BillBoard checks this page against public Congress.gov metadata, then adds plain-English analysis where available.

Bill
SRES 786
Congress
119th Congress
Official title
A resolution designating July 15, 2026, as "Glioblastoma Awareness Day".
Policy area
Healthcare
Latest action
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (June 23, 2026)
Last updated
June 24, 2026
FOR
  • Brain cancer patients and families They value national recognition of a disease that is often devastating and difficult to treat. An awareness day can help families feel seen and can encourage earlier conversations about symptoms, treatment options, and clinical trials.
  • Medical researchers and cancer advocates Public observances can help sustain attention on underfunded diseases and support fundraising for research. Even without direct funding, the resolution can strengthen outreach around prevention, detection, and new therapies.
  • Hospitals and oncology clinicians Clinicians often support awareness efforts that improve public understanding of serious cancers. Greater visibility can help people seek care sooner and may increase participation in research studies and support services.
AGAINST
  • Fiscal conservatives concerned about symbolic legislation They may argue that Congress should focus floor time on measures with direct policy impact rather than commemorative resolutions. In their view, symbolic designations can crowd out more substantive work without changing outcomes.
  • Advocates for direct disease funding Some may say awareness observances are not enough unless paired with actual research dollars or treatment initiatives. They may prefer legislation that delivers measurable support for NIH, cancer centers, or patient assistance.
  • Members concerned about calendar congestion in the Senate Routine commemorative resolutions can add to legislative clutter, especially when they do not create binding obligations. Critics may prefer fewer stand-alone observances and more consolidated public-health action.
  • "designating July 15, 2026, as 'Glioblastoma Awareness Day'"

    This creates an official national observance on a specific date. It can be used by advocacy groups, hospitals, and families to organize education and fundraising efforts around glioblastoma.

  • "considered, and agreed to without amendment"

    The Senate approved the resolution in the form it was introduced, without changing the wording. That usually signals the measure was noncontroversial and broadly acceptable to senators present.

  • "with a preamble by Unanimous Consent"

    Unanimous consent is a fast-track procedure used for measures that draw no objection. In practice, it means the Senate treated the resolution as a consensus recognition rather than a contested policy fight.

June 23, 2026

Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.

This resolution has already been agreed to by the Senate by unanimous consent, which is the typical path for commemorative measures of this kind. Simple Senate resolutions do not become law or require presidential signature; they express the chamber’s view and usually pass when they attract broad, noncontroversial support. The lack of committee activity and the bipartisan-style coalescence around a health awareness observance also make final Senate approval very likely, and in this case it has already occurred.

Take Action

Get more from BillBoard

Free tools to understand, respond to, and track this bill.

Ask AI about this bill

Data sourced from api.congress.gov.

Free to use · No credit card

Understand every bill.
Make your voice count.

BillBoard turns dense U.S. legislation into plain-English summaries, helps you take a stance, and connects you to your representatives — in seconds.